Imperial College London


Faculty of MedicineInstitute of Clinical Sciences

Professor of Biochemistry



+44 (0)20 3313 4313david.carling




3rd Fl CRBHammersmith HospitalHammersmith Campus






Hope D, Hinds C, Lopes T, et al., 2022, Hypoaminoacidemia underpins glucagon-mediated energy expenditure and weight loss, Cell Reports Medicine, Vol:3, ISSN:2666-3791

Carling D, 2022, Inhibiting lysosomal aldolase: a magic bullet for AMPK activation in treating metabolic disease?, Life Metabolism

McGlone ER, Dunsterville C, Carling D, et al., 2022, Hepatocyte cholesterol content modulates glucagon receptor signalling, Molecular Metabolism, Vol:63, ISSN:2212-8778

Widjaja AA, Viswanathan S, Wei Ting JG, et al., 2022, IL11 stimulates ERK/P90RSK to inhibit LKB1/AMPK and activate mTOR initiating a mesenchymal program in stromal, epithelial, and cancer cells, Iscience, Vol:25, ISSN:2589-0042


Kabir L, Maughan R, Paschalaki K, et al., 2022, Evidence for Mitochondrial Dysfunction in Blood-derived Endothelial Colony Forming Cells Isolated from Patients with Antiphospholipid Syndrome, WILEY, Pages:4515-4516, ISSN:2326-5191

More Publications